Nuvalent director Matthew Shair resigns; Ron Squarer elected to board

Nuvalent, Inc.

Matthew Shair, Ph.D., resigned from the Board effective Dec 9, 2025, and not due to any disagreement.
Ron Squarer elected as Class II independent director effective Dec 10, 2025, until 2026 annual meeting.
Squarer receives initial equity award with aggregate fair value $600,000 (option + RSU).
Option capped at 14,850 shares, RSU capped at 7,425 shares; vesting over 3 years.
Squarer eligible for annual director cash retainers and committee fees per policy.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.